Loading ......
Filter By Product Search for
CLCN2
CLCN2 Full Name
chloride channel, voltage-sensitive 2
CLCN2 Introduction
CLCN2 (Chloride Channel, Voltage-Sensitive 2) is a member of the CLC family of chloride transport proteins, which function as either anion channels or chloride/proton exchangers. Unlike its better-known relatives CLC-1 (muscle) and CLC-K (kidney), CLCN2 is ubiquitously expressed across diverse tissues, including the brain, lung, intestine, and testis. It is a double-barreled homodimer, meaning each subunit contains its own pore, yet both pores gate independently in response to membrane voltage. This channel is specifically activated by hyperpolarization (negative membrane potentials) and is modulated by extracellular pH and cell swelling, positioning it as a critical sensor for both electrical and osmotic changes in the cellular environment.
Figure 1.Identification of the CLCN2 A506V variant and genetic analysis of mutant ClC-2. (Yu L, Jiang W, Cao L, et al.2026)
Physiological Roles Across Organ Systems
In the central nervous system, CLCN2 is predominantly expressed in astrocytes and oligodendrocytes, where it contributes to the regulation of extracellular chloride homeostasis – a key factor in GABAergic inhibitory neurotransmission. Disruption of this channel alters the chloride reversal potential, potentially affecting seizure thresholds. In the lungs and intestinal epithelia, CLCN2 provides an alternative pathway for fluid secretion and absorption, working in concert with CFTR (Cystic Fibrosis Transmembrane Regulator) to maintain mucosal hydration. Moreover, in the male reproductive tract, CLCN2 is highly enriched in the acrosome of spermatozoa, where it may facilitate the capacitation process by modulating intracellular chloride levels. This broad tissue distribution underscores its role as a housekeeping channel that responds to both local and systemic demands.
Pathophysiological Implications and Disease Associations
Loss-of-function mutations in the CLCN2 gene have been linked to a rare leukodystrophy known as CLCN2-related leukoencephalopathy, characterized by myelin vacuolation and cerebellar ataxia, along with cognitive decline. Interestingly, these patients often present with testicular dysfunction and visual impairment, reflecting the channel's multi-organ relevance. Conversely, aberrant overexpression of CLCN2 has been observed in certain gliomas and gastric cancers, where it appears to promote cell migration and invasion by facilitating local acid–base balance and volume regulation. These dual faces – deficiency causing neurodegeneration and excess driving oncogenesis – make CLCN2 an emerging target for both neuromodulatory and antineoplastic strategies, though pharmacological tools remain in early development.
Alternate Names for CLCN2
CLCN2; chloride channel, voltage-sensitive 2; chloride channel 2; chloride channel protein 2; ClC 2; CLC2; EJM6; ECA2; ECA3; EGI3; EGMA; EJM8; CIC-2; EGI11; clC-2;
Loading ......